These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37983245)

  • 1. Mayaro virus pathogenesis and immunity in rhesus macaques.
    Weber WC; Labriola CS; Kreklywich CN; Ray K; Haese NN; Andoh TF; Denton M; Medica S; Streblow MM; Smith PP; Mizuno N; Frias N; Fisher MB; Barber-Axthelm AM; Chun K; Uttke S; Whitcomb D; DeFilippis V; Rakshe S; Fei SS; Axthelm MK; Smedley JV; Streblow DN
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011742. PubMed ID: 37983245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
    Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
    J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses.
    Powers JM; Haese NN; Denton M; Ando T; Kreklywich C; Bonin K; Streblow CE; Kreklywich N; Smith P; Broeckel R; DeFilippis V; Morrison TE; Heise MT; Streblow DN
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009308. PubMed ID: 33793555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque.
    Hamilton MM; Webb EM; Peterson MC; Patel G; Porto M; Orekov T; Erasmus JH; Finneyfrock B; Cook A; Auguste AJ; Kar S
    J Gen Virol; 2024 Jul; 105(7):. PubMed ID: 38995674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Efficacy of Mayaro Virus-Like Particle Vaccines Produced in Insect or Mammalian Cells.
    Abbo SR; Nguyen W; Abma-Henkens MHC; van de Kamer D; Savelkoul NHA; Geertsema C; Le TTT; Tang B; Yan K; Dumenil T; van Oers MM; Suhrbier A; Pijlman GP
    J Virol; 2023 Mar; 97(3):e0160122. PubMed ID: 36883812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
    Campos RK; Preciado-Llanes L; Azar SR; Kim YC; Brandon O; López-Camacho C; Reyes-Sandoval A; Rossi SL
    Front Immunol; 2020; 11():591885. PubMed ID: 33224148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Chikungunya virus immunity on Mayaro virus disease and epidemic potential.
    Webb EM; Azar SR; Haller SL; Langsjoen RM; Cuthbert CE; Ramjag AT; Luo H; Plante K; Wang T; Simmons G; Carrington CVF; Weaver SC; Rossi SL; Auguste AJ
    Sci Rep; 2019 Dec; 9(1):20399. PubMed ID: 31892710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection Pattern of Mayaro Virus in Aedes aegypti (Diptera: Culicidae) and Transmission Potential of the Virus in Mixed Infections With Chikungunya Virus.
    Kantor AM; Lin J; Wang A; Thompson DC; Franz AWE
    J Med Entomol; 2019 Apr; 56(3):832-843. PubMed ID: 30668762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease.
    Mota MTO; Costa VV; Sugimoto MA; Guimarães GF; Queiroz-Junior CM; Moreira TP; de Sousa CD; Santos FM; Queiroz VF; Passos I; Hubner J; Souza DG; Weaver SC; Teixeira MM; Nogueira ML
    Sci Rep; 2020 Mar; 10(1):5306. PubMed ID: 32210270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of the CCL2-CCR2 axis in Mayaro virus-induced disease.
    Santos FM; Costa VRdM; Araújo Sd; Sousa CDFd; Moreira TP; Gonçalves MR; Santos ACPMd; Ferreira HAS; Costa PAC; Barrioni BR; Bargi-Souza P; Pereira MdM; Nogueira ML; Souza DdG; Guimarães PPG; Teixeira MM; Queiroz-Junior CM; Costa VV
    J Virol; 2024 Jan; 98(1):e0110223. PubMed ID: 38169294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model.
    Chen CI; Clark DC; Pesavento P; Lerche NW; Luciw PA; Reisen WK; Brault AC
    Am J Trop Med Hyg; 2010 Dec; 83(6):1249-58. PubMed ID: 21118930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
    Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
    mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses.
    Malonis RJ; Earnest JT; Kim AS; Angeliadis M; Holtsberg FW; Aman MJ; Jangra RK; Chandran K; Daily JP; Diamond MS; Kielian M; Lai JR
    Proc Natl Acad Sci U S A; 2021 Sep; 118(37):. PubMed ID: 34507983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress.
    Camini FC; da Silva TF; da Silva Caetano CC; Almeida LT; Ferraz AC; Alves Vitoreti VM; de Mello Silva B; de Queiroz Silva S; de Magalhães JC; de Brito Magalhães CL
    Antiviral Res; 2018 Oct; 158():8-12. PubMed ID: 30076863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus.
    Fumagalli MJ; de Souza WM; Romeiro MF; de Souza Costa MC; Slhessarenko RD; Figueiredo LTM
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mayaro Virus Replication Restriction and Induction of Muscular Inflammation in Mice Are Dependent on Age, Type-I Interferon Response, and Adaptive Immunity.
    Figueiredo CM; Neris RLDS; Gavino-Leopoldino D; da Silva MOL; Almeida JS; Dos-Santos JS; Figueiredo CP; Bellio M; Bozza MT; Assunção-Miranda I
    Front Microbiol; 2019; 10():2246. PubMed ID: 31632368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favipiravir Inhibits Mayaro Virus Infection in Mice.
    Bengue M; Pintong AR; Liegeois F; Nougairède A; Hamel R; Pompon J; de Lamballerie X; Roques P; Choumet V; Missé D
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mayaro virus infection elicits a robust pro-inflammatory and antiviral response in human macrophages.
    Hernández-Sarmiento LJ; Tamayo-Molina YS; Valdés-López JF; Urcuqui-Inchima S
    Acta Trop; 2024 Apr; 252():107146. PubMed ID: 38342287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection.
    Ferraz AC; Almeida LT; da Silva Caetano CC; da Silva Menegatto MB; Souza Lima RL; de Senna JPN; de Oliveira Cardoso JM; Perucci LO; Talvani A; Geraldo de Lima W; de Mello Silva B; Barbosa Reis A; de Magalhães JC; Lopes de Brito Magalhães C
    Antiviral Res; 2021 Oct; 194():105168. PubMed ID: 34437912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mayaro Virus Infects Human Brain Cells and Induces a Potent Antiviral Response in Human Astrocytes.
    Bengue M; Ferraris P; Barthelemy J; Diagne CT; Hamel R; Liégeois F; Nougairède A; de Lamballerie X; Simonin Y; Pompon J; Salinas S; Missé D
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33799906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.